Former NFL Player Tony Mandarich to Appear on Modavox's VoiceAmerica™ Sports Network Show "Ray Ellis Sports"

Business Wire, Oct 6, 2008

Interview to Discuss Steroid Use, His Life Threatening Addiction to Pain Killers and Alcohol and His New Book, "My Dirty Little Secrets - Steroids, Alcohol & God - The Tony Mandarich Story"

PHOENIX -- Modavox, Inc. (OTCBB:MDVX), Internet broadcasting pioneer and holder of several patented technologies, today announced that former NFL player Tony Mandarich will be interviewed on the Company's VoiceAmerica[TM] Sports Network program "Ray Ellis Sports" (www.rayellissports.com) live Tuesday October 7th at 1pm PST and 4pm EST.

The former football star will sit down with former fellow NFL player Ray Ellis for a one on one interview hot on the heals of his news-breaking exclusive interview with Armen Keteyian for INSIDE THE NFL on SHOWTIME which aired Wednesday, Oct. 1. In that interview Mandarich admitted for the first time ever that he used anabolic steroids while at Michigan State. Mandarich also revealed that he had a life-threatening addiction to pain killers and alcohol prior to entering the NFL, which continued during his three-year tenure with the Green Bay Packers. He also confessed to cheating on his drug test while playing for Michigan State in the Rose Bowl.

The two will discuss these issues in addition to the upcoming release of Mandarich's new book "My Dirty Little Secrets - Steroids, Alcohol & God - The Tony Mandarich Story," which will be released in March 2009, nearly 20 years after he was drafted into the NFL.

Jeff Spenard, Modavox President of Internet Radio stated, "We're pleased that our VoiceAmerica[TM] Sports Network continues to attract the attention and interest of notable professional athletes like Tony Mandarich. Our platform continues to uniquely provide guests like him the ability to tell their story in their own words. We continue to remain focused on producing both high quality programming as well as content. The forthcoming launching of the 'O and Hodge' as well as this interview with Tony continue to illustrate the scalability of our offerings as well as demonstrating how our unique platform can be leveraged by all sorts of athletes to build their audience and their brand."

About Tony Mandarich

Tony Mandarich (tonymandarich.com) is a former football offensive lineman of the NFL. He was the first round draft pick of the Green Bay Packers in 1989, second overall behind Hall of Fame quarterback Troy Aikman and ahead of the third selection, Hall of Fame running back Barry Sanders. Playing at Michigan State University, Mandarich played in the 1988 Rose Bowl, was named as a first-team All-American, an Outland Award finalist and a two-time Big Ten Lineman of the Year. Upon his entry into the 1989 NFL Draft, both scouts and media (most notably Sports Illustrated, which did a cover story on him, famously naming him "The Incredible Bulk") began trumpeting Mandarich as the best offensive line prospect ever. He appeared on the cover of Sports Illustrated twice.

About Modavox

Modavox, Inc., the customized communications company, is a pioneer in Internet broadcasting, producing and syndicating online audio and video, offering innovative, effective, and comprehensive online tools for reaching targeted niche communities worldwide. Through patented Modavox technology, Modavox delivers content straight to desktops and Internet-enabled devices. Modavox provides managed access for live and on-demand Internet radio broadcasting, e-learning and rich media advertising. For more information, please visit www.modavox.com.

Forward-Looking Statements

This release contains "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause Modavox's actual results to differ materially from those currently anticipated, including the risk factors identified in Modavox's filings with the Securities and Exchange Commission.